{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P63000",
      "entity_text" : "Rac1",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:Q9UKW4",
      "entity_text" : "VAV3",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "VAV3, another novel SMG that was mutated in 2.3% of HCC, has also been shown to promote prostate cancer metastasis through activating Rac1 XREF_BIBR.",
  "reading_complete" : "2020-08-03T09:28:08Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T09:27:07Z",
  "trigger" : "promote",
  "evidence" : [ "VAV3, another novel SMG that was mutated in 2.3% of HCC, has also been shown to promote prostate cancer metastasis through activating Rac1" ],
  "pmc_id" : "5858179",
  "score" : 0
}